“From Data to Discovery: Leveraging Systems Biology and AI to Accelerate Translational Medicine”

4 November 2026 | 4 – 5 pm CET | Webinar

AI and systems biology are reshaping biopharmaceutical research and drug development. Join us to discover how these technologies can support better decision-making at every stage, from identifying promising drug targets to Phase IV clinical trials. Through real-world examples, we will explore the potential of combining biostatistical methods, mechanistic modeling, and AI to bridge the gap between scientific discoveries and clinical outcomes.

SPARK Europe invites you to join the webinar on 4 November at 16:00 CET to gain valuable insights from Dr Darya Orlova, Chief Scientific Officer at Intercellular Inc., who brings over 15 years of experience in computational and translational biology and expertise in areas such as spatial and single-cell omics and AI-enabled target and biomarker discovery.

The webinar, hosted by SPARK Faculty of Medicine, Masaryk University, will take place online - please register here.